{"gene":"POLG","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2001,"finding":"POLG encodes the only DNA polymerase responsible for mtDNA replication; heterozygous missense mutation Y955C in the polymerase motif B causes dominant progressive external ophthalmoplegia with accumulation of large-scale mtDNA deletions, establishing POLG as the sole replicative polymerase in mitochondria.","method":"Genetic mapping, sequencing, and identification of mutations in patient pedigrees","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational study replicated across many subsequent labs establishing POLG as the sole mitochondrial replicative polymerase","pmids":["11431686"],"is_preprint":false},{"year":2004,"finding":"Homozygous Glu873Stop mutation in POLG exon 17 (upstream of polymerase domain) combined with Ala467Thr substitution in exon 7 (linker region) causes deficiency in mitochondrial DNA polymerase gamma catalytic activity, leading to mtDNA depletion and Alpers syndrome.","method":"POLG gene sequencing in patient pedigrees, biochemical characterization of catalytic activity deficiency","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic identification with biochemical catalytic activity measurement, single lab","pmids":["15122711"],"is_preprint":false},{"year":2005,"finding":"The common A467T mutation in POLG reduces DNA polymerase activity to ~4% of wild-type, primarily via a 6-fold reduction in kcat with minimal effect on exonuclease function, and disrupts physical association with the 55-kDa accessory subunit (p55), abolishing processivity stimulation by the accessory subunit.","method":"In vitro biochemical assays (processivity, heat inactivation, N-ethylmaleimide protection, thermolysin digestion, immunoprecipitation) with purified recombinant A467T mutant enzyme","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple in vitro biochemical assays with purified recombinant enzyme, multiple orthogonal methods in one rigorous study","pmids":["16024923"],"is_preprint":false},{"year":2003,"finding":"Mutations in the exonuclease domain of POLG1 reduce its proofreading 3'-5' exonuclease activity, resulting in accumulation of heteroplasmic mtDNA point mutations in skeletal muscle and fibroblasts, demonstrating that POLG's exonuclease domain is required for mtDNA fidelity.","method":"Large-scale screening of mtDNA molecules from skeletal muscle by PCR and sequencing in PEO patients with POLG1 exonuclease domain mutations","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cells with defined POLG exonuclease domain mutations, multiple mutation types analyzed, single lab","pmids":["14557557"],"is_preprint":false},{"year":2007,"finding":"Expression of catalytically deficient POLG1 mutants in human cell culture causes severe mtDNA replication stalling and copy number reduction, but still displays delayed lagging-strand synthesis characteristic of strand-asynchronous replication, whereas Twinkle mutant stalling results in fully double-stranded DNA intermediates.","method":"Expression of catalytic mutants of POLG1 in human cell culture, analysis of replication intermediates","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined catalytic mutants in human cells with mechanistic analysis of replication intermediates, single lab","pmids":["17452351"],"is_preprint":false},{"year":2008,"finding":"mtDNA depletion in patient fibroblasts requires at least one allele with a missense mutation in a catalytic domain (polymerase or exonuclease) or a nonsense mutation; patients with two linker-region mutations only show normal mtDNA content, demonstrating that catalytic domain integrity is specifically required for mtDNA maintenance.","method":"Cellular mtDNA content measurement in fibroblasts from 24 patients with defined POLG1 genotypes; mosaic depletion patterns in culture","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genotype-phenotype correlation across 24 patients, direct cellular mtDNA quantification with clear domain-function relationship","pmids":["18487244"],"is_preprint":false},{"year":2011,"finding":"The G517V substitution in POLG retains 80-90% of wild-type DNA polymerase activity in vitro and maintains functional interaction with the p55 accessory subunit and near-normal DNA binding, indicating this variant is unlikely to be pathogenic by itself.","method":"Biochemical analysis of purified recombinant human DNA polymerase γ G517V protein: polymerase activity assays, accessory subunit interaction, DNA binding","journal":"Mitochondrion","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro with purified recombinant enzyme, multiple orthogonal biochemical assays, single lab; negative result is mechanistically informative","pmids":["21856450"],"is_preprint":false},{"year":2012,"finding":"MtDNA mutagenesis from defective POLG exonuclease activity leads to dysfunction of neural stem cells (NSC) and hematopoietic progenitor cells (HPC) early in development, with NSC showing decreased self-renewal and HPCs showing abnormal lineage differentiation; N-acetyl-L-cysteine treatment rescued both abnormalities, implicating subtle ROS/redox changes as the mechanism.","method":"PolgA mutator mouse model: in vitro NSC self-renewal assays, in vivo NSC quantification, HPC lineage analysis, N-acetyl-L-cysteine rescue experiments","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mouse model with multiple cellular assays and pharmacological rescue, multiple orthogonal methods","pmids":["22225879"],"is_preprint":false},{"year":2005,"finding":"Transcripts of POLG bearing the E873stop premature termination codon undergo nonsense-mediated decay and nonsense-associated alternative splicing, resulting in >95% of functional POLG mRNA being derived from the A467T allele, demonstrating that mono-allelic POLG expression can cause Alpers syndrome.","method":"Western blot, RT-PCR analysis of POLG transcripts in patient fibroblasts with E873stop/A467T genotype","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mechanistic analysis of mRNA processing in patient-derived fibroblasts with two orthogonal methods (Western blot + RT-PCR), single lab","pmids":["16181814"],"is_preprint":false},{"year":2018,"finding":"In starving yeast cells, POLG (mtDNA polymerase γ) continuously synthesizes mtDNA, but this synthesis is inhibited by nucleotide insufficiency and elevated mitochondria-derived ROS when autophagy is impaired; after prolonged starvation, POLG's 3'-5' exonuclease activity degrades mtDNA, causing quantitative mtDNA instability and irreversible respiratory dysfunction in autophagy-deficient cells.","method":"Yeast genetics (autophagy mutants), mtDNA copy number measurement, respiratory function assays, nucleotide pool measurements","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast genetic model with multiple functional readouts and epistasis analysis, mechanistically dissects synthetic vs degradative POLG modes","pmids":["29519802"],"is_preprint":false},{"year":2020,"finding":"A CUG triplet in the 5' leader of POLG mRNA initiates translation of a conserved 260-codon overlapping reading frame (POLGARF) with ~60-70% efficiency relative to AUG; unprocessed POLGARF localizes to nucleoli with its interacting partner C1QBP, and serum stimulation causes rapid cleavage and secretion of a POLGARF C-terminal fragment, suggesting a role in extracellular signaling.","method":"Reporter assays for CUG initiation efficiency, subcellular localization (live imaging), Co-IP with C1QBP, serum stimulation and secretion assays, ribosome profiling, phylogenetic analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods in one study: reporter assays, Co-IP, localization imaging, secretion assays, ribosome profiling","pmids":["32958672"],"is_preprint":false},{"year":2020,"finding":"ERα (ESR1/Esr1) binds the POLG1 (Polg1) promoter in 3T3L1 adipocytes, directly controlling POLG1 expression; adipose-selective Esr1 deletion reduces Polg1 expression and causes mitochondrial dysfunction in white and brown adipocytes.","method":"Chromatin immunoprecipitation (ChIP) assay for ERα binding to Polg1 promoter; adipose-selective Esr1 knockout mice; measurement of mtDNA content and mitochondrial function","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter binding plus in vivo KO model, single lab","pmids":["32759275"],"is_preprint":false},{"year":2023,"finding":"PARP1 translocates from the nucleus to mitochondria upon lactate stimulation in VSMCs, directly binds POLG and inhibits POLG-mediated mitochondrial DNA synthesis, leading to downregulation of mitochondria-encoded genes and impaired oxidative phosphorylation; PARP1 knockdown partially reverses this mtDNA replication impairment.","method":"Co-immunoprecipitation (Co-IP) of PARP1 and POLG, PARP1 knockdown, measurement of mitochondrial gene expression and respiration in VSMC coculture model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP interaction plus knockdown rescue, single lab, multiple functional readouts","pmids":["37679327"],"is_preprint":false},{"year":2025,"finding":"PARP1-mediated PARylation of POLG in calcified VSMCs triggers ubiquitination-dependent POLG degradation, leading to mitochondrial dysfunction and activation of Adora2a/Rap1 signaling that induces VSMC ferroptosis and promotes vascular calcification; PARP1 inhibition restores POLG levels and mitigates calcification.","method":"RNA-sequencing, POLG overexpression and AAV9-sh-POLG knockdown in vivo, PARP1 KO mice (Parp1flox/flox Tagln Cre+), immunoprecipitation for PARylation and ubiquitination of POLG","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo models with genetic manipulation and biochemical characterization of PTM, single lab","pmids":["40401372"],"is_preprint":false},{"year":2019,"finding":"Increasing mitochondrial dNTP pools via deoxyribonucleoside supplementation promotes mtDNA repopulation in POLG-deficient human fibroblasts without compromising POLG fidelity (no increase in deletions or point mutations detected), demonstrating that physiological dNTP concentration limits POLG-mediated mtDNA replication rate.","method":"mtDNA copy number recovery assay in quiescent patient fibroblasts following ethidium bromide depletion, dNTP pool measurement, deletion/mutation analysis","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct manipulation of dNTP pools in patient-derived cells with multiple readouts, single lab","pmids":["30848931"],"is_preprint":false},{"year":2021,"finding":"POLG binds to PKM2 by co-immunoprecipitation and affects Tyr105-site phosphorylation of PKM2, thereby interfering with glycolysis in gastric cancer cells; POLG silencing increases glycolytic rate and tumor proliferation in vitro and in vivo.","method":"Co-immunoprecipitation (Co-IP) of PolG and PKM2, lentiviral silencing, glycolysis functional assays, xenograft tumor growth","journal":"Cancer management and research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP with limited mechanistic follow-up, single lab, no reconstitution","pmids":["33623435"],"is_preprint":false},{"year":2020,"finding":"In lens epithelial cells, the lncRNA OIP5-AS1 acts via HuR as a scaffold to mediate decay of POLG mRNA; POLG depletion decreases mtDNA copy number and mitochondrial membrane potential and increases ROS, sensitizing cells to apoptosis. POLG overexpression reverses these effects.","method":"Ribonucleoprotein immunoprecipitation-qPCR (RIP-qPCR) for OIP5-AS1/HuR/POLG mRNA interaction; POLG overexpression and knockdown; JC-1 staining and ROS measurement","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP-qPCR for RNA-protein interaction plus functional rescue experiments, multiple orthogonal methods, single lab","pmids":["33006594"],"is_preprint":false},{"year":2025,"finding":"Muscle-specific inducible POLG mutation causes rapid mitochondrial dysfunction and muscular degeneration, with robust activation of the mitochondrial integrated stress response (mtISR) and striking depletion of the folate cycle metabolite 5,10-methenyl-THF, identifying imbalanced folate intermediates as a novel pathology linking the mtISR and mitochondrial disease.","method":"Inducible tissue-specific PolG mutant mouse model, detailed molecular profiling, metabolomics, mtISR pathway analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific genetic model with detailed molecular and metabolic profiling, single lab, novel mechanistic finding","pmids":["40057508"],"is_preprint":false},{"year":2014,"finding":"Heterozygous Polg D257A knock-in mice (proofreading-deficient) accumulate multiple mtDNA deletions in an age-dependent and tissue-specific manner in muscles and brain, leading to motor dysfunction, without significant accumulation of point mutations or mtDNA depletion.","method":"Rotarod behavioral testing, tissue-specific mtDNA deletion analysis by PCR, point mutation quantification in heterozygous knock-in mice","journal":"Annals of clinical and translational neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined genetic mouse model with behavioral and molecular phenotyping, multiple tissues analyzed, single lab","pmids":["25540805"],"is_preprint":false},{"year":2015,"finding":"DNA methylation at exon 2 of POLG (POLGA) regulates mtDNA copy number: highly proliferative cancer and pluripotent cells are heavily methylated at exon 2 with low mtDNA copy number; demethylation (via 5-azacytidine treatment) increases POLG expression and mtDNA copy number, demonstrating epigenetic regulation of POLG controls mtDNA levels and cellular differentiation.","method":"Immunoprecipitation of 5mC and 5hmC (MeDIP/hMeDIP), quantitative PCR for mtDNA copy number, 5-azacytidine treatment, cancer cell differentiation assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell types and orthogonal methylation analysis methods, functional rescue, single lab","pmids":["25719248"],"is_preprint":false}],"current_model":"POLG encodes the sole mitochondrial DNA polymerase (pol γ), which replicates and repairs mtDNA via its 5'-3' polymerase and 3'-5' proofreading exonuclease activities in a heterotrimeric holoenzyme that requires physical association with the p55 accessory subunit (encoded by POLG2) for processive DNA synthesis; disease mutations in the polymerase or exonuclease catalytic domains impair mtDNA replication (causing depletion or deletions), while linker-region mutations primarily disrupt accessory subunit interaction; POLG activity is regulated by mitochondrial dNTP availability, autophagy-dependent nucleotide homeostasis, PARP1-mediated PARylation and ubiquitination, epigenetic methylation of its promoter/exon 2, and transcriptional control by ERα, and additionally produces an alternative overlapping protein (POLGARF) via CUG-initiated translation from its 5' leader."},"narrative":{"mechanistic_narrative":"POLG encodes the sole DNA polymerase responsible for mitochondrial DNA replication, and its catalytic integrity governs both mtDNA copy number and sequence fidelity [PMID:11431686, PMID:18487244]. The enzyme couples a 5'-3' polymerase activity to a 3'-5' proofreading exonuclease: catalytic-domain missense or nonsense mutations cause mtDNA depletion or large-scale deletions, exonuclease-domain mutations specifically erode proofreading and allow accumulation of heteroplasmic point mutations, and processive synthesis requires physical association with the p55 accessory subunit, which the common A467T linker variant disrupts while only mildly reducing intrinsic catalysis [PMID:11431686, PMID:16024923, PMID:14557557, PMID:18487244]. Mutations in POLG underlie dominant progressive external ophthalmoplegia and, when catalytic activity is compromised, Alpers syndrome [PMID:11431686, PMID:15122711]; the latter can arise from a single functional allele because the partner allele is silenced by nonsense-mediated decay [PMID:16181814]. POLG-dependent mtDNA synthesis is limited by mitochondrial dNTP availability [PMID:30848931] and is dynamically controlled by autophagy-dependent nucleotide and ROS homeostasis, with prolonged starvation switching POLG to a degradative exonucleolytic mode [PMID:29519802]. POLG abundance is set transcriptionally by ERα binding to its promoter [PMID:32759275], epigenetically by DNA methylation of exon 2 that tunes mtDNA copy number across proliferative and pluripotent states [PMID:25719248], and post-translationally by PARP1, which binds POLG to inhibit mtDNA synthesis and drives its PARylation- and ubiquitination-dependent degradation [PMID:37679327, PMID:40401372]. The POLG locus additionally produces POLGARF, a distinct nucleolar/secreted protein translated via CUG initiation from an overlapping reading frame in the 5' leader, in complex with C1QBP [PMID:32958672]. At the organismal level, loss of POLG fidelity impairs neural and hematopoietic progenitors through redox imbalance [PMID:22225879] and provokes a folate-cycle-linked mitochondrial integrated stress response in muscle [PMID:40057508].","teleology":[{"year":2001,"claim":"Established that POLG is the sole replicative polymerase of mitochondria and that its dysfunction underlies a human disease of mtDNA instability, defining the gene's core biological role.","evidence":"Genetic mapping and mutation identification (Y955C in polymerase motif B) in dominant PEO pedigrees","pmids":["11431686"],"confidence":"High","gaps":["Did not biochemically dissect how Y955C alters catalysis","Mechanism linking single-mutation polymerase defect to large-scale deletions not resolved"]},{"year":2003,"claim":"Showed that the proofreading exonuclease domain is required for replication fidelity, separating fidelity control from polymerization.","evidence":"PCR/sequencing of mtDNA from skeletal muscle and fibroblasts of PEO patients with exonuclease-domain mutations","pmids":["14557557"],"confidence":"Medium","gaps":["Patient-derived correlation rather than reconstituted exonuclease kinetics","Did not isolate exonuclease defect from concurrent polymerase effects"]},{"year":2004,"claim":"Linked catalytic-activity-deficient POLG genotypes to mtDNA depletion and Alpers syndrome, distinguishing depletion from deletion phenotypes.","evidence":"POLG sequencing plus biochemical catalytic activity measurement in patient pedigrees (E873stop/A467T)","pmids":["15122711"],"confidence":"Medium","gaps":["Contribution of each allele to the deficit not separated in this study","Single lab"]},{"year":2005,"claim":"Resolved why the common A467T variant is pathogenic — it cripples turnover and abolishes p55 accessory-subunit interaction and processivity stimulation rather than acting through the exonuclease.","evidence":"Multiple orthogonal in vitro assays with purified recombinant A467T enzyme (processivity, immunoprecipitation, proteolysis protection)","pmids":["16024923"],"confidence":"High","gaps":["Structural basis of disrupted accessory-subunit binding not determined"]},{"year":2005,"claim":"Explained how a compound heterozygous genotype produces disease through mono-allelic expression, with the nonsense allele degraded by NMD.","evidence":"Western blot and RT-PCR of POLG transcripts in E873stop/A467T patient fibroblasts","pmids":["16181814"],"confidence":"Medium","gaps":["Generality of NMD-driven mono-allelic expression across other POLG genotypes untested"]},{"year":2007,"claim":"Distinguished the replication-stalling signature of POLG catalytic mutants from that of the Twinkle helicase, placing POLG within strand-asynchronous mtDNA replication.","evidence":"Expression of catalytic POLG mutants in human cells with analysis of replication intermediates","pmids":["17452351"],"confidence":"Medium","gaps":["Did not define the molecular trigger of lagging-strand delay","Single lab"]},{"year":2008,"claim":"Defined the genotype-function rule that depletion requires a catalytic-domain or nonsense lesion, whereas two linker mutations preserve copy number.","evidence":"mtDNA quantification across 24 patient fibroblast genotypes","pmids":["18487244"],"confidence":"Medium","gaps":["Correlative; mechanistic basis of linker-only tolerance not biochemically tested"]},{"year":2011,"claim":"Provided a mechanistically informative negative control by showing G517V retains activity, p55 interaction and DNA binding, refining variant pathogenicity criteria.","evidence":"Purified recombinant G517V biochemical assays (polymerase activity, accessory-subunit interaction, DNA binding)","pmids":["21856450"],"confidence":"High","gaps":["Behavior in compound-heterozygous context not addressed"]},{"year":2012,"claim":"Connected POLG proofreading loss to stem/progenitor cell dysfunction via redox imbalance, extending mtDNA fidelity to tissue homeostasis.","evidence":"PolgA mutator mouse with NSC/HPC assays and N-acetyl-L-cysteine rescue","pmids":["22225879"],"confidence":"High","gaps":["Precise ROS source and downstream signaling not pinpointed"]},{"year":2014,"claim":"Demonstrated that heterozygous proofreading deficiency produces age- and tissue-specific mtDNA deletions and motor dysfunction without depletion or point-mutation load.","evidence":"Polg D257A knock-in mice with rotarod testing and tissue mtDNA deletion/point-mutation analysis","pmids":["25540805"],"confidence":"Medium","gaps":["Mechanism converting proofreading loss to deletions rather than point mutations unresolved"]},{"year":2015,"claim":"Identified epigenetic methylation at POLG exon 2 as a regulator of mtDNA copy number tied to proliferation and differentiation state.","evidence":"MeDIP/hMeDIP, mtDNA qPCR, and 5-azacytidine demethylation across cancer and pluripotent cells","pmids":["25719248"],"confidence":"Medium","gaps":["Enzymes setting/erasing the exon-2 mark not identified","Single lab"]},{"year":2018,"claim":"Revealed that POLG operates in two opposing modes — synthetic versus exonucleolytic degradation — governed by autophagy-dependent nucleotide and ROS homeostasis during starvation.","evidence":"Yeast autophagy mutants with mtDNA copy number, respiration, and nucleotide pool measurements","pmids":["29519802"],"confidence":"High","gaps":["Whether the same starvation switch operates in mammalian cells not shown here"]},{"year":2019,"claim":"Showed that physiological dNTP concentration rate-limits POLG-mediated mtDNA repopulation, and that supplementation boosts copy number without sacrificing fidelity.","evidence":"Deoxyribonucleoside supplementation in quiescent patient fibroblasts with dNTP and deletion/mutation analysis","pmids":["30848931"],"confidence":"Medium","gaps":["Did not test fidelity effects in proofreading-mutant backgrounds"]},{"year":2020,"claim":"Established transcriptional control of POLG by ERα, linking nuclear hormone signaling to mtDNA maintenance in adipose tissue.","evidence":"ChIP for ERα at the Polg1 promoter plus adipose-selective Esr1 knockout mice","pmids":["32759275"],"confidence":"Medium","gaps":["Direct ERα regulation of human POLG in non-adipose tissues untested"]},{"year":2020,"claim":"Uncovered POLGARF, an overlapping CUG-initiated protein from the POLG leader with nucleolar localization, C1QBP interaction, and regulated secretion, expanding the locus's coding capacity.","evidence":"CUG-initiation reporter assays, live imaging, Co-IP with C1QBP, secretion assays, ribosome profiling, phylogenetics","pmids":["32958672"],"confidence":"High","gaps":["Physiological function of the secreted POLGARF fragment not defined","Relationship between POLGARF and pol gamma activity unknown"]},{"year":2020,"claim":"Identified post-transcriptional control of POLG mRNA stability via an OIP5-AS1/HuR scaffold, coupling lncRNA regulation to mitochondrial integrity in lens cells.","evidence":"RIP-qPCR for OIP5-AS1/HuR/POLG mRNA plus POLG knockdown/overexpression with JC-1 and ROS readouts","pmids":["33006594"],"confidence":"Medium","gaps":["Generality beyond lens epithelial cells unaddressed"]},{"year":2023,"claim":"Showed PARP1 relocalizes to mitochondria and directly binds and inhibits POLG-mediated mtDNA synthesis, defining a post-translational brake on replication.","evidence":"PARP1/POLG Co-IP, PARP1 knockdown, mitochondrial gene-expression and respiration readouts in VSMCs","pmids":["37679327"],"confidence":"Medium","gaps":["Single Co-IP without structural mapping of the interaction","Direct vs indirect inhibition not fully separated"]},{"year":2025,"claim":"Extended PARP1 regulation to PARylation- and ubiquitination-dependent POLG degradation driving ferroptosis and vascular calcification, linking POLG turnover to disease.","evidence":"PARP1 KO mice, POLG overexpression/knockdown in vivo, and IP for POLG PARylation and ubiquitination","pmids":["40401372"],"confidence":"Medium","gaps":["E3 ligase mediating POLG ubiquitination not identified","Single lab"]},{"year":2025,"claim":"Connected muscle POLG dysfunction to the mitochondrial integrated stress response and a specific folate-cycle metabolite depletion, a novel metabolic axis of mitochondrial disease.","evidence":"Inducible muscle-specific PolG mutant mice with metabolomics and mtISR pathway profiling","pmids":["40057508"],"confidence":"Medium","gaps":["Causal role of 5,10-methenyl-THF depletion in pathology not tested by rescue"]},{"year":null,"claim":"How the multiple regulatory layers — dNTP supply, autophagy, ERα transcription, exon-2 methylation, and PARP1-driven PTMs — are integrated to set POLG activity and mtDNA copy number in different tissues remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model coordinating transcriptional, post-transcriptional, and post-translational POLG control","Physiological role of POLGARF relative to pol gamma undefined","Structural basis of disease-mutation effects on the holoenzyme not solved within this corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,2,3,4,9]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,14]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,4,9,12]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[0,4,5]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[3,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1,13]}],"complexes":["pol gamma holoenzyme (POLG–p55/POLG2)"],"partners":["POLG2","PARP1","C1QBP","PKM2","ESR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P54098","full_name":"DNA polymerase subunit gamma-1","aliases":["3'-5' exodeoxyribonuclease","5'-deoxyribose-phosphate lyase","Mitochondrial DNA polymerase catalytic subunit","PolG-alpha"],"length_aa":1239,"mass_kda":139.6,"function":"Catalytic subunit of DNA polymerase gamma solely responsible for replication of mitochondrial DNA (mtDNA). Replicates both heavy and light strands of the circular mtDNA genome using a single-stranded DNA template, RNA primers and the four deoxyribonucleoside triphosphates as substrates (PubMed:11477093, PubMed:11897778, PubMed:15917273, PubMed:19837034, PubMed:9558343). Has 5' -> 3' polymerase activity. Functionally interacts with TWNK and SSBP1 at the replication fork to form a highly processive replisome, where TWNK unwinds the double-stranded DNA template prior to replication and SSBP1 covers the parental heavy strand to enable continuous replication of the entire mitochondrial genome. A single nucleotide incorporation cycle includes binding of the incoming nucleotide at the insertion site, a phosphodiester bond formation reaction that extends the 3'-end of the primer DNA, and translocation of the primer terminus to the post-insertion site. After completing replication of a mtDNA strand, mediates 3' -> 5' exonucleolytic degradation at the nick to enable proper ligation (PubMed:11477093, PubMed:11897778, PubMed:15167897, PubMed:15917273, PubMed:19837034, PubMed:26095671, PubMed:9558343). Highly accurate due to high nucleotide selectivity and 3' -> 5' exonucleolytic proofreading. Proficiently corrects base substitutions, single-base additions and deletions in non-repetitive sequences and short repeats, but displays lower proofreading activity when replicating longer homopolymeric stretches. Exerts exonuclease activity toward single-stranded DNA and double-stranded DNA containing 3'-terminal mispairs. When a misincorporation occurs, transitions from replication to a pro-nucleolytic editing mode and removes the missincorporated nucleoside in the exonuclease active site. Proceeds via an SN2 nucleolytic mechanism in which Asp-198 catalyzes phosphodiester bond hydrolysis and Glu-200 stabilizes the leaving group. As a result the primer strand becomes one nucleotide shorter and is positioned in the post-insertion site, ready to resume DNA synthesis (PubMed:10827171, PubMed:11477094, PubMed:11504725, PubMed:37202477). Exerts 5'-deoxyribose phosphate (dRP) lyase activity and mediates repair-associated mtDNA synthesis (gap filling) in base-excision repair pathway. Catalyzes the release of the 5'-terminal 2-deoxyribose-5-phosphate sugar moiety from incised apurinic/apyrimidinic (AP) sites to produce a substrate for DNA ligase. The dRP lyase reaction does not require divalent metal ions and likely proceeds via a Schiff base intermediate in a beta-elimination reaction mechanism (PubMed:9770471)","subcellular_location":"Mitochondrion; Mitochondrion matrix, mitochondrion nucleoid","url":"https://www.uniprot.org/uniprotkb/P54098/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLG","classification":"Not Classified","n_dependent_lines":314,"n_total_lines":1208,"dependency_fraction":0.2599337748344371},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POLG","total_profiled":1310},"omim":[{"mim_id":"620759","title":"POLG ALTERNATIVE READING FRAME; POLGARF","url":"https://www.omim.org/entry/620759"},{"mim_id":"618528","title":"MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16","url":"https://www.omim.org/entry/618528"},{"mim_id":"618100","title":"MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE; MPV17L","url":"https://www.omim.org/entry/618100"},{"mim_id":"613662","title":"MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B","url":"https://www.omim.org/entry/613662"},{"mim_id":"610131","title":"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4","url":"https://www.omim.org/entry/610131"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLG"},"hgnc":{"alias_symbol":["POLG1","POLGA"],"prev_symbol":[]},"alphafold":{"accession":"P54098","domains":[{"cath_id":"3.30.420.390","chopping":"160-314_347-417","consensus_level":"medium","plddt":89.0797,"start":160,"end":417},{"cath_id":"-","chopping":"924-1075_1083-1088","consensus_level":"medium","plddt":84.3605,"start":924,"end":1088}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P54098","model_url":"https://alphafold.ebi.ac.uk/files/AF-P54098-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P54098-F1-predicted_aligned_error_v6.png","plddt_mean":78.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLG","jax_strain_url":"https://www.jax.org/strain/search?query=POLG"},"sequence":{"accession":"P54098","fasta_url":"https://rest.uniprot.org/uniprotkb/P54098.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P54098/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P54098"}},"corpus_meta":[{"pmid":"11431686","id":"PMC_11431686","title":"Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11431686","citation_count":638,"is_preprint":false},{"pmid":"15122711","id":"PMC_15122711","title":"POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.","date":"2004","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15122711","citation_count":325,"is_preprint":false},{"pmid":"30451971","id":"PMC_30451971","title":"POLG-related disorders and their neurological manifestations.","date":"2019","source":"Nature reviews. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30451971","citation_count":313,"is_preprint":false},{"pmid":"18546365","id":"PMC_18546365","title":"Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18546365","citation_count":223,"is_preprint":false},{"pmid":"15477547","id":"PMC_15477547","title":"POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement.","date":"2004","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15477547","citation_count":209,"is_preprint":false},{"pmid":"22225879","id":"PMC_22225879","title":"Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice.","date":"2012","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22225879","citation_count":193,"is_preprint":false},{"pmid":"21038416","id":"PMC_21038416","title":"Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.","date":"2010","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21038416","citation_count":158,"is_preprint":false},{"pmid":"19010300","id":"PMC_19010300","title":"DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19010300","citation_count":127,"is_preprint":false},{"pmid":"17452351","id":"PMC_17452351","title":"Expression of catalytic mutants of the mtDNA helicase Twinkle and polymerase POLG causes distinct replication stalling phenotypes.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17452351","citation_count":125,"is_preprint":false},{"pmid":"12825077","id":"PMC_12825077","title":"Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy.","date":"2003","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/12825077","citation_count":125,"is_preprint":false},{"pmid":"12707443","id":"PMC_12707443","title":"Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO).","date":"2003","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12707443","citation_count":123,"is_preprint":false},{"pmid":"18238797","id":"PMC_18238797","title":"POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection.","date":"2008","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18238797","citation_count":118,"is_preprint":false},{"pmid":"16024923","id":"PMC_16024923","title":"The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16024923","citation_count":114,"is_preprint":false},{"pmid":"32759275","id":"PMC_32759275","title":"Estrogen receptor α controls metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32759275","citation_count":99,"is_preprint":false},{"pmid":"15929042","id":"PMC_15929042","title":"POLG mutations and Alpers syndrome.","date":"2005","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15929042","citation_count":97,"is_preprint":false},{"pmid":"25719248","id":"PMC_25719248","title":"Mitochondrial DNA copy number is regulated by DNA methylation and demethylation of POLGA in stem and cancer cells and their differentiated progeny.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25719248","citation_count":96,"is_preprint":false},{"pmid":"23545419","id":"PMC_23545419","title":"Clinical and molecular features of POLG-related mitochondrial disease.","date":"2013","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/23545419","citation_count":96,"is_preprint":false},{"pmid":"14635118","id":"PMC_14635118","title":"POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/14635118","citation_count":81,"is_preprint":false},{"pmid":"20558295","id":"PMC_20558295","title":"The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.","date":"2010","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/20558295","citation_count":77,"is_preprint":false},{"pmid":"16896309","id":"PMC_16896309","title":"POLG1 mutations associated with progressive encephalopathy in childhood.","date":"2006","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16896309","citation_count":74,"is_preprint":false},{"pmid":"19578034","id":"PMC_19578034","title":"The unfolding clinical spectrum of POLG mutations.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19578034","citation_count":67,"is_preprint":false},{"pmid":"14688158","id":"PMC_14688158","title":"Frequent polymorphism of the mitochondrial DNA polymerase gamma gene (POLG) in patients with normal spermiograms and unexplained subfertility.","date":"2004","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14688158","citation_count":67,"is_preprint":false},{"pmid":"27554452","id":"PMC_27554452","title":"Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review.","date":"2016","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/27554452","citation_count":65,"is_preprint":false},{"pmid":"17420318","id":"PMC_17420318","title":"Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism.","date":"2007","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17420318","citation_count":65,"is_preprint":false},{"pmid":"18294203","id":"PMC_18294203","title":"Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.","date":"2008","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/18294203","citation_count":64,"is_preprint":false},{"pmid":"16957900","id":"PMC_16957900","title":"Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.","date":"2006","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/16957900","citation_count":61,"is_preprint":false},{"pmid":"29519802","id":"PMC_29519802","title":"Autophagy balances mtDNA synthesis and degradation by DNA polymerase POLG during starvation.","date":"2018","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29519802","citation_count":54,"is_preprint":false},{"pmid":"14557557","id":"PMC_14557557","title":"Remarkable infidelity of polymerase gammaA associated with mutations in POLG1 exonuclease domain.","date":"2003","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14557557","citation_count":53,"is_preprint":false},{"pmid":"21993618","id":"PMC_21993618","title":"Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.","date":"2011","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21993618","citation_count":52,"is_preprint":false},{"pmid":"18487244","id":"PMC_18487244","title":"Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18487244","citation_count":52,"is_preprint":false},{"pmid":"16401742","id":"PMC_16401742","title":"Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.","date":"2006","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16401742","citation_count":51,"is_preprint":false},{"pmid":"22528963","id":"PMC_22528963","title":"Characterizing POLG ataxia: clinics, electrophysiology and imaging.","date":"2012","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22528963","citation_count":49,"is_preprint":false},{"pmid":"32840960","id":"PMC_32840960","title":"Disease-specific phenotypes in iPSC-derived neural stem cells with POLG mutations.","date":"2020","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32840960","citation_count":48,"is_preprint":false},{"pmid":"15356024","id":"PMC_15356024","title":"The clinical significance of the POLG gene polymorphism in male infertility.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15356024","citation_count":48,"is_preprint":false},{"pmid":"21221844","id":"PMC_21221844","title":"POLG1-related and other \"mitochondrial Parkinsonisms\": an overview.","date":"2011","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/21221844","citation_count":45,"is_preprint":false},{"pmid":"25585994","id":"PMC_25585994","title":"Evidence for polymerase gamma, POLG1 variation in reduced mitochondrial DNA copy number in Parkinson's disease.","date":"2015","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25585994","citation_count":45,"is_preprint":false},{"pmid":"20399836","id":"PMC_20399836","title":"POLG1 polyglutamine tract variants associated with Parkinson's disease.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20399836","citation_count":44,"is_preprint":false},{"pmid":"20643228","id":"PMC_20643228","title":"Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas.","date":"2010","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/20643228","citation_count":42,"is_preprint":false},{"pmid":"26735972","id":"PMC_26735972","title":"A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26735972","citation_count":42,"is_preprint":false},{"pmid":"21357833","id":"PMC_21357833","title":"POLG1 manifestations in childhood.","date":"2011","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21357833","citation_count":41,"is_preprint":false},{"pmid":"24725338","id":"PMC_24725338","title":"Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24725338","citation_count":40,"is_preprint":false},{"pmid":"32958672","id":"PMC_32958672","title":"Unusually efficient CUG initiation of an overlapping reading frame in POLG mRNA yields novel protein POLGARF.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32958672","citation_count":40,"is_preprint":false},{"pmid":"19251978","id":"PMC_19251978","title":"Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19251978","citation_count":39,"is_preprint":false},{"pmid":"19748572","id":"PMC_19748572","title":"Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excluding the mitochondrial gamma polymerase, POLG1).","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19748572","citation_count":37,"is_preprint":false},{"pmid":"16181814","id":"PMC_16181814","title":"Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome.","date":"2005","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16181814","citation_count":36,"is_preprint":false},{"pmid":"25203713","id":"PMC_25203713","title":"POLG1-related levodopa-responsive parkinsonism.","date":"2014","source":"Clinical neurology and neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/25203713","citation_count":34,"is_preprint":false},{"pmid":"28480171","id":"PMC_28480171","title":"Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database.","date":"2017","source":"BBA clinical","url":"https://pubmed.ncbi.nlm.nih.gov/28480171","citation_count":34,"is_preprint":false},{"pmid":"37679327","id":"PMC_37679327","title":"Exploring a new mechanism between lactate and VSMC calcification: PARP1/POLG/UCP2 signaling pathway and imbalance of mitochondrial homeostasis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37679327","citation_count":33,"is_preprint":false},{"pmid":"22729384","id":"PMC_22729384","title":"Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with POLG and SURF1 mutations.","date":"2012","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22729384","citation_count":33,"is_preprint":false},{"pmid":"15694274","id":"PMC_15694274","title":"Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.","date":"2004","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15694274","citation_count":33,"is_preprint":false},{"pmid":"35993394","id":"PMC_35993394","title":"Premature aging is associated with higher levels of 8-oxoguanine and increased DNA damage in the Polg mutator mouse.","date":"2022","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/35993394","citation_count":32,"is_preprint":false},{"pmid":"23542163","id":"PMC_23542163","title":"Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice.","date":"2013","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/23542163","citation_count":32,"is_preprint":false},{"pmid":"19815814","id":"PMC_19815814","title":"Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease.","date":"2009","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19815814","citation_count":32,"is_preprint":false},{"pmid":"20837861","id":"PMC_20837861","title":"POLG1 variations presenting as multiple sclerosis.","date":"2010","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20837861","citation_count":31,"is_preprint":false},{"pmid":"21235791","id":"PMC_21235791","title":"Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome.","date":"2011","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21235791","citation_count":29,"is_preprint":false},{"pmid":"25118206","id":"PMC_25118206","title":"A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity.","date":"2014","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25118206","citation_count":29,"is_preprint":false},{"pmid":"18321754","id":"PMC_18321754","title":"Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene.","date":"2008","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/18321754","citation_count":29,"is_preprint":false},{"pmid":"32138667","id":"PMC_32138667","title":"Evidence for a novel overlapping coding sequence in POLG initiated at a CUG start codon.","date":"2020","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32138667","citation_count":28,"is_preprint":false},{"pmid":"20803511","id":"PMC_20803511","title":"POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe.","date":"2010","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/20803511","citation_count":28,"is_preprint":false},{"pmid":"20826197","id":"PMC_20826197","title":"Variations of the CAG trinucleotide repeat in DNA polymerase γ (POLG1) is associated with Parkinson's disease in Sweden.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20826197","citation_count":27,"is_preprint":false},{"pmid":"20385918","id":"PMC_20385918","title":"Is it ADEM, POLG, or both?","date":"2010","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20385918","citation_count":26,"is_preprint":false},{"pmid":"34631714","id":"PMC_34631714","title":"Nicotinamide Riboside and Metformin Ameliorate Mitophagy Defect in Induced Pluripotent Stem Cell-Derived Astrocytes With POLG Mutations.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34631714","citation_count":26,"is_preprint":false},{"pmid":"20142534","id":"PMC_20142534","title":"A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes.","date":"2010","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20142534","citation_count":25,"is_preprint":false},{"pmid":"27987238","id":"PMC_27987238","title":"Enrichment of deleterious variants of mitochondrial DNA polymerase gene (POLG1) in bipolar disorder.","date":"2017","source":"Psychiatry and clinical neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/27987238","citation_count":25,"is_preprint":false},{"pmid":"22000311","id":"PMC_22000311","title":"Alpers syndrome with mutations in POLG: clinical and investigative features.","date":"2011","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22000311","citation_count":25,"is_preprint":false},{"pmid":"31843010","id":"PMC_31843010","title":"Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene.","date":"2019","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/31843010","citation_count":24,"is_preprint":false},{"pmid":"21670405","id":"PMC_21670405","title":"Novel POLG splice site mutation and optic atrophy.","date":"2011","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21670405","citation_count":24,"is_preprint":false},{"pmid":"26468652","id":"PMC_26468652","title":"Mitochondrial DNA Polymerase POLG1 Disease Mutations and Germline Variants Promote Tumorigenic Properties.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26468652","citation_count":23,"is_preprint":false},{"pmid":"33264635","id":"PMC_33264635","title":"N-acetylcysteine amide ameliorates mitochondrial dysfunction and reduces oxidative stress in hiPSC-derived dopaminergic neurons with POLG mutation.","date":"2020","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33264635","citation_count":23,"is_preprint":false},{"pmid":"30941926","id":"PMC_30941926","title":"POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review.","date":"2019","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/30941926","citation_count":23,"is_preprint":false},{"pmid":"30848931","id":"PMC_30848931","title":"Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30848931","citation_count":22,"is_preprint":false},{"pmid":"33006594","id":"PMC_33006594","title":"Long Noncoding RNA OIP5-AS1 Promotes Cell Apoptosis and Cataract Formation by Blocking POLG Expression Under Oxidative Stress.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/33006594","citation_count":22,"is_preprint":false},{"pmid":"16682683","id":"PMC_16682683","title":"POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions.","date":"2006","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16682683","citation_count":22,"is_preprint":false},{"pmid":"22963882","id":"PMC_22963882","title":"Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population.","date":"2012","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/22963882","citation_count":21,"is_preprint":false},{"pmid":"16715201","id":"PMC_16715201","title":"A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy.","date":"2006","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16715201","citation_count":21,"is_preprint":false},{"pmid":"33469036","id":"PMC_33469036","title":"Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33469036","citation_count":21,"is_preprint":false},{"pmid":"25660390","id":"PMC_25660390","title":"The in cis T251I and P587L POLG1 base changes: description of a new family and literature review.","date":"2015","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/25660390","citation_count":20,"is_preprint":false},{"pmid":"25540805","id":"PMC_25540805","title":"Heterozygous Polg mutation causes motor dysfunction due to mtDNA deletions.","date":"2014","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25540805","citation_count":20,"is_preprint":false},{"pmid":"21856450","id":"PMC_21856450","title":"Biochemical analysis of the G517V POLG variant reveals wild-type like activity.","date":"2011","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/21856450","citation_count":20,"is_preprint":false},{"pmid":"26212336","id":"PMC_26212336","title":"MitoRCA-seq reveals unbalanced cytocine to thymine transition in Polg mutant mice.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26212336","citation_count":20,"is_preprint":false},{"pmid":"32596975","id":"PMC_32596975","title":"Hallmarks of frailty and osteosarcopenia in prematurely aged PolgA(D257A/D257A) mice.","date":"2020","source":"Journal of cachexia, sarcopenia and muscle","url":"https://pubmed.ncbi.nlm.nih.gov/32596975","citation_count":19,"is_preprint":false},{"pmid":"37969736","id":"PMC_37969736","title":"Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication.","date":"2023","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/37969736","citation_count":19,"is_preprint":false},{"pmid":"28130605","id":"PMC_28130605","title":"Novel POLG mutations and variable clinical phenotypes in 13 Italian patients.","date":"2017","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/28130605","citation_count":18,"is_preprint":false},{"pmid":"26607151","id":"PMC_26607151","title":"Pure Progressive Ataxia and Palatal Tremor (PAPT) Associated with a New Polymerase Gamma (POLG) Mutation.","date":"2016","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26607151","citation_count":18,"is_preprint":false},{"pmid":"23251356","id":"PMC_23251356","title":"Association of mitochondrial DNA polymerase γ gene POLG1 polymorphisms with parkinsonism in Chinese populations.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23251356","citation_count":17,"is_preprint":false},{"pmid":"28634151","id":"PMC_28634151","title":"Speech and swallowing abnormalities in adults with POLG associated ataxia (POLG-A).","date":"2017","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/28634151","citation_count":17,"is_preprint":false},{"pmid":"36280265","id":"PMC_36280265","title":"The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgAD257A/D257A Mitochondrial Mutator Mice.","date":"2022","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36280265","citation_count":16,"is_preprint":false},{"pmid":"29341116","id":"PMC_29341116","title":"Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29341116","citation_count":16,"is_preprint":false},{"pmid":"40057508","id":"PMC_40057508","title":"Mitochondrial damage in muscle specific PolG mutant mice activates the integrated stress response and disrupts the mitochondrial folate cycle.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40057508","citation_count":15,"is_preprint":false},{"pmid":"20438629","id":"PMC_20438629","title":"POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.","date":"2010","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20438629","citation_count":15,"is_preprint":false},{"pmid":"33623435","id":"PMC_33623435","title":"PolG Inhibits Gastric Cancer Glycolysis and Viability by Suppressing PKM2 Phosphorylation.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33623435","citation_count":15,"is_preprint":false},{"pmid":"30103161","id":"PMC_30103161","title":"Specific EEG markers in POLG1 Alpers' syndrome.","date":"2018","source":"Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/30103161","citation_count":15,"is_preprint":false},{"pmid":"21654874","id":"PMC_21654874","title":"Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation?","date":"2011","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/21654874","citation_count":15,"is_preprint":false},{"pmid":"27553587","id":"PMC_27553587","title":"Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(-/-) mice.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27553587","citation_count":14,"is_preprint":false},{"pmid":"40401372","id":"PMC_40401372","title":"PARylation of POLG Mediated by PARP1 Accelerates Ferroptosis-Induced Vascular Calcification via Activating Adora2a/Rap1 Signaling.","date":"2025","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40401372","citation_count":13,"is_preprint":false},{"pmid":"23865558","id":"PMC_23865558","title":"Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonism.","date":"2013","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23865558","citation_count":13,"is_preprint":false},{"pmid":"26104464","id":"PMC_26104464","title":"The spectrum of epilepsy caused by POLG mutations.","date":"2015","source":"Acta neurologica Belgica","url":"https://pubmed.ncbi.nlm.nih.gov/26104464","citation_count":13,"is_preprint":false},{"pmid":"31613174","id":"PMC_31613174","title":"Novel POLG mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy.","date":"2019","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31613174","citation_count":13,"is_preprint":false},{"pmid":"25466440","id":"PMC_25466440","title":"Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report.","date":"2014","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/25466440","citation_count":13,"is_preprint":false},{"pmid":"29992832","id":"PMC_29992832","title":"Identification of the first homozygous POLG mutation causing non-syndromic ovarian dysfunction.","date":"2018","source":"Climacteric : the journal of the International Menopause Society","url":"https://pubmed.ncbi.nlm.nih.gov/29992832","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48399,"output_tokens":4936,"usd":0.109618,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13287,"output_tokens":5169,"usd":0.09783,"stage2_stop_reason":"end_turn"},"total_usd":0.207448,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"POLG encodes the only DNA polymerase responsible for mtDNA replication; heterozygous missense mutation Y955C in the polymerase motif B causes dominant progressive external ophthalmoplegia with accumulation of large-scale mtDNA deletions, establishing POLG as the sole replicative polymerase in mitochondria.\",\n      \"method\": \"Genetic mapping, sequencing, and identification of mutations in patient pedigrees\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational study replicated across many subsequent labs establishing POLG as the sole mitochondrial replicative polymerase\",\n      \"pmids\": [\"11431686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Homozygous Glu873Stop mutation in POLG exon 17 (upstream of polymerase domain) combined with Ala467Thr substitution in exon 7 (linker region) causes deficiency in mitochondrial DNA polymerase gamma catalytic activity, leading to mtDNA depletion and Alpers syndrome.\",\n      \"method\": \"POLG gene sequencing in patient pedigrees, biochemical characterization of catalytic activity deficiency\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic identification with biochemical catalytic activity measurement, single lab\",\n      \"pmids\": [\"15122711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The common A467T mutation in POLG reduces DNA polymerase activity to ~4% of wild-type, primarily via a 6-fold reduction in kcat with minimal effect on exonuclease function, and disrupts physical association with the 55-kDa accessory subunit (p55), abolishing processivity stimulation by the accessory subunit.\",\n      \"method\": \"In vitro biochemical assays (processivity, heat inactivation, N-ethylmaleimide protection, thermolysin digestion, immunoprecipitation) with purified recombinant A467T mutant enzyme\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple in vitro biochemical assays with purified recombinant enzyme, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"16024923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mutations in the exonuclease domain of POLG1 reduce its proofreading 3'-5' exonuclease activity, resulting in accumulation of heteroplasmic mtDNA point mutations in skeletal muscle and fibroblasts, demonstrating that POLG's exonuclease domain is required for mtDNA fidelity.\",\n      \"method\": \"Large-scale screening of mtDNA molecules from skeletal muscle by PCR and sequencing in PEO patients with POLG1 exonuclease domain mutations\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cells with defined POLG exonuclease domain mutations, multiple mutation types analyzed, single lab\",\n      \"pmids\": [\"14557557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Expression of catalytically deficient POLG1 mutants in human cell culture causes severe mtDNA replication stalling and copy number reduction, but still displays delayed lagging-strand synthesis characteristic of strand-asynchronous replication, whereas Twinkle mutant stalling results in fully double-stranded DNA intermediates.\",\n      \"method\": \"Expression of catalytic mutants of POLG1 in human cell culture, analysis of replication intermediates\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined catalytic mutants in human cells with mechanistic analysis of replication intermediates, single lab\",\n      \"pmids\": [\"17452351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"mtDNA depletion in patient fibroblasts requires at least one allele with a missense mutation in a catalytic domain (polymerase or exonuclease) or a nonsense mutation; patients with two linker-region mutations only show normal mtDNA content, demonstrating that catalytic domain integrity is specifically required for mtDNA maintenance.\",\n      \"method\": \"Cellular mtDNA content measurement in fibroblasts from 24 patients with defined POLG1 genotypes; mosaic depletion patterns in culture\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genotype-phenotype correlation across 24 patients, direct cellular mtDNA quantification with clear domain-function relationship\",\n      \"pmids\": [\"18487244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The G517V substitution in POLG retains 80-90% of wild-type DNA polymerase activity in vitro and maintains functional interaction with the p55 accessory subunit and near-normal DNA binding, indicating this variant is unlikely to be pathogenic by itself.\",\n      \"method\": \"Biochemical analysis of purified recombinant human DNA polymerase γ G517V protein: polymerase activity assays, accessory subunit interaction, DNA binding\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro with purified recombinant enzyme, multiple orthogonal biochemical assays, single lab; negative result is mechanistically informative\",\n      \"pmids\": [\"21856450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MtDNA mutagenesis from defective POLG exonuclease activity leads to dysfunction of neural stem cells (NSC) and hematopoietic progenitor cells (HPC) early in development, with NSC showing decreased self-renewal and HPCs showing abnormal lineage differentiation; N-acetyl-L-cysteine treatment rescued both abnormalities, implicating subtle ROS/redox changes as the mechanism.\",\n      \"method\": \"PolgA mutator mouse model: in vitro NSC self-renewal assays, in vivo NSC quantification, HPC lineage analysis, N-acetyl-L-cysteine rescue experiments\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mouse model with multiple cellular assays and pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"22225879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Transcripts of POLG bearing the E873stop premature termination codon undergo nonsense-mediated decay and nonsense-associated alternative splicing, resulting in >95% of functional POLG mRNA being derived from the A467T allele, demonstrating that mono-allelic POLG expression can cause Alpers syndrome.\",\n      \"method\": \"Western blot, RT-PCR analysis of POLG transcripts in patient fibroblasts with E873stop/A467T genotype\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mechanistic analysis of mRNA processing in patient-derived fibroblasts with two orthogonal methods (Western blot + RT-PCR), single lab\",\n      \"pmids\": [\"16181814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In starving yeast cells, POLG (mtDNA polymerase γ) continuously synthesizes mtDNA, but this synthesis is inhibited by nucleotide insufficiency and elevated mitochondria-derived ROS when autophagy is impaired; after prolonged starvation, POLG's 3'-5' exonuclease activity degrades mtDNA, causing quantitative mtDNA instability and irreversible respiratory dysfunction in autophagy-deficient cells.\",\n      \"method\": \"Yeast genetics (autophagy mutants), mtDNA copy number measurement, respiratory function assays, nucleotide pool measurements\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast genetic model with multiple functional readouts and epistasis analysis, mechanistically dissects synthetic vs degradative POLG modes\",\n      \"pmids\": [\"29519802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A CUG triplet in the 5' leader of POLG mRNA initiates translation of a conserved 260-codon overlapping reading frame (POLGARF) with ~60-70% efficiency relative to AUG; unprocessed POLGARF localizes to nucleoli with its interacting partner C1QBP, and serum stimulation causes rapid cleavage and secretion of a POLGARF C-terminal fragment, suggesting a role in extracellular signaling.\",\n      \"method\": \"Reporter assays for CUG initiation efficiency, subcellular localization (live imaging), Co-IP with C1QBP, serum stimulation and secretion assays, ribosome profiling, phylogenetic analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods in one study: reporter assays, Co-IP, localization imaging, secretion assays, ribosome profiling\",\n      \"pmids\": [\"32958672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ERα (ESR1/Esr1) binds the POLG1 (Polg1) promoter in 3T3L1 adipocytes, directly controlling POLG1 expression; adipose-selective Esr1 deletion reduces Polg1 expression and causes mitochondrial dysfunction in white and brown adipocytes.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assay for ERα binding to Polg1 promoter; adipose-selective Esr1 knockout mice; measurement of mtDNA content and mitochondrial function\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter binding plus in vivo KO model, single lab\",\n      \"pmids\": [\"32759275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PARP1 translocates from the nucleus to mitochondria upon lactate stimulation in VSMCs, directly binds POLG and inhibits POLG-mediated mitochondrial DNA synthesis, leading to downregulation of mitochondria-encoded genes and impaired oxidative phosphorylation; PARP1 knockdown partially reverses this mtDNA replication impairment.\",\n      \"method\": \"Co-immunoprecipitation (Co-IP) of PARP1 and POLG, PARP1 knockdown, measurement of mitochondrial gene expression and respiration in VSMC coculture model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP interaction plus knockdown rescue, single lab, multiple functional readouts\",\n      \"pmids\": [\"37679327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PARP1-mediated PARylation of POLG in calcified VSMCs triggers ubiquitination-dependent POLG degradation, leading to mitochondrial dysfunction and activation of Adora2a/Rap1 signaling that induces VSMC ferroptosis and promotes vascular calcification; PARP1 inhibition restores POLG levels and mitigates calcification.\",\n      \"method\": \"RNA-sequencing, POLG overexpression and AAV9-sh-POLG knockdown in vivo, PARP1 KO mice (Parp1flox/flox Tagln Cre+), immunoprecipitation for PARylation and ubiquitination of POLG\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo models with genetic manipulation and biochemical characterization of PTM, single lab\",\n      \"pmids\": [\"40401372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Increasing mitochondrial dNTP pools via deoxyribonucleoside supplementation promotes mtDNA repopulation in POLG-deficient human fibroblasts without compromising POLG fidelity (no increase in deletions or point mutations detected), demonstrating that physiological dNTP concentration limits POLG-mediated mtDNA replication rate.\",\n      \"method\": \"mtDNA copy number recovery assay in quiescent patient fibroblasts following ethidium bromide depletion, dNTP pool measurement, deletion/mutation analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct manipulation of dNTP pools in patient-derived cells with multiple readouts, single lab\",\n      \"pmids\": [\"30848931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"POLG binds to PKM2 by co-immunoprecipitation and affects Tyr105-site phosphorylation of PKM2, thereby interfering with glycolysis in gastric cancer cells; POLG silencing increases glycolytic rate and tumor proliferation in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation (Co-IP) of PolG and PKM2, lentiviral silencing, glycolysis functional assays, xenograft tumor growth\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP with limited mechanistic follow-up, single lab, no reconstitution\",\n      \"pmids\": [\"33623435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In lens epithelial cells, the lncRNA OIP5-AS1 acts via HuR as a scaffold to mediate decay of POLG mRNA; POLG depletion decreases mtDNA copy number and mitochondrial membrane potential and increases ROS, sensitizing cells to apoptosis. POLG overexpression reverses these effects.\",\n      \"method\": \"Ribonucleoprotein immunoprecipitation-qPCR (RIP-qPCR) for OIP5-AS1/HuR/POLG mRNA interaction; POLG overexpression and knockdown; JC-1 staining and ROS measurement\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP-qPCR for RNA-protein interaction plus functional rescue experiments, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"33006594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Muscle-specific inducible POLG mutation causes rapid mitochondrial dysfunction and muscular degeneration, with robust activation of the mitochondrial integrated stress response (mtISR) and striking depletion of the folate cycle metabolite 5,10-methenyl-THF, identifying imbalanced folate intermediates as a novel pathology linking the mtISR and mitochondrial disease.\",\n      \"method\": \"Inducible tissue-specific PolG mutant mouse model, detailed molecular profiling, metabolomics, mtISR pathway analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific genetic model with detailed molecular and metabolic profiling, single lab, novel mechanistic finding\",\n      \"pmids\": [\"40057508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Heterozygous Polg D257A knock-in mice (proofreading-deficient) accumulate multiple mtDNA deletions in an age-dependent and tissue-specific manner in muscles and brain, leading to motor dysfunction, without significant accumulation of point mutations or mtDNA depletion.\",\n      \"method\": \"Rotarod behavioral testing, tissue-specific mtDNA deletion analysis by PCR, point mutation quantification in heterozygous knock-in mice\",\n      \"journal\": \"Annals of clinical and translational neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined genetic mouse model with behavioral and molecular phenotyping, multiple tissues analyzed, single lab\",\n      \"pmids\": [\"25540805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DNA methylation at exon 2 of POLG (POLGA) regulates mtDNA copy number: highly proliferative cancer and pluripotent cells are heavily methylated at exon 2 with low mtDNA copy number; demethylation (via 5-azacytidine treatment) increases POLG expression and mtDNA copy number, demonstrating epigenetic regulation of POLG controls mtDNA levels and cellular differentiation.\",\n      \"method\": \"Immunoprecipitation of 5mC and 5hmC (MeDIP/hMeDIP), quantitative PCR for mtDNA copy number, 5-azacytidine treatment, cancer cell differentiation assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell types and orthogonal methylation analysis methods, functional rescue, single lab\",\n      \"pmids\": [\"25719248\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLG encodes the sole mitochondrial DNA polymerase (pol γ), which replicates and repairs mtDNA via its 5'-3' polymerase and 3'-5' proofreading exonuclease activities in a heterotrimeric holoenzyme that requires physical association with the p55 accessory subunit (encoded by POLG2) for processive DNA synthesis; disease mutations in the polymerase or exonuclease catalytic domains impair mtDNA replication (causing depletion or deletions), while linker-region mutations primarily disrupt accessory subunit interaction; POLG activity is regulated by mitochondrial dNTP availability, autophagy-dependent nucleotide homeostasis, PARP1-mediated PARylation and ubiquitination, epigenetic methylation of its promoter/exon 2, and transcriptional control by ERα, and additionally produces an alternative overlapping protein (POLGARF) via CUG-initiated translation from its 5' leader.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLG encodes the sole DNA polymerase responsible for mitochondrial DNA replication, and its catalytic integrity governs both mtDNA copy number and sequence fidelity [#0, #5]. The enzyme couples a 5'-3' polymerase activity to a 3'-5' proofreading exonuclease: catalytic-domain missense or nonsense mutations cause mtDNA depletion or large-scale deletions, exonuclease-domain mutations specifically erode proofreading and allow accumulation of heteroplasmic point mutations, and processive synthesis requires physical association with the p55 accessory subunit, which the common A467T linker variant disrupts while only mildly reducing intrinsic catalysis [#0, #2, #3, #5]. Mutations in POLG underlie dominant progressive external ophthalmoplegia and, when catalytic activity is compromised, Alpers syndrome [#0, #1]; the latter can arise from a single functional allele because the partner allele is silenced by nonsense-mediated decay [#8]. POLG-dependent mtDNA synthesis is limited by mitochondrial dNTP availability [#14] and is dynamically controlled by autophagy-dependent nucleotide and ROS homeostasis, with prolonged starvation switching POLG to a degradative exonucleolytic mode [#9]. POLG abundance is set transcriptionally by ERα binding to its promoter [#11], epigenetically by DNA methylation of exon 2 that tunes mtDNA copy number across proliferative and pluripotent states [#19], and post-translationally by PARP1, which binds POLG to inhibit mtDNA synthesis and drives its PARylation- and ubiquitination-dependent degradation [#12, #13]. The POLG locus additionally produces POLGARF, a distinct nucleolar/secreted protein translated via CUG initiation from an overlapping reading frame in the 5' leader, in complex with C1QBP [#10]. At the organismal level, loss of POLG fidelity impairs neural and hematopoietic progenitors through redox imbalance [#7] and provokes a folate-cycle-linked mitochondrial integrated stress response in muscle [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established that POLG is the sole replicative polymerase of mitochondria and that its dysfunction underlies a human disease of mtDNA instability, defining the gene's core biological role.\",\n      \"evidence\": \"Genetic mapping and mutation identification (Y955C in polymerase motif B) in dominant PEO pedigrees\",\n      \"pmids\": [\"11431686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not biochemically dissect how Y955C alters catalysis\", \"Mechanism linking single-mutation polymerase defect to large-scale deletions not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed that the proofreading exonuclease domain is required for replication fidelity, separating fidelity control from polymerization.\",\n      \"evidence\": \"PCR/sequencing of mtDNA from skeletal muscle and fibroblasts of PEO patients with exonuclease-domain mutations\",\n      \"pmids\": [\"14557557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Patient-derived correlation rather than reconstituted exonuclease kinetics\", \"Did not isolate exonuclease defect from concurrent polymerase effects\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Linked catalytic-activity-deficient POLG genotypes to mtDNA depletion and Alpers syndrome, distinguishing depletion from deletion phenotypes.\",\n      \"evidence\": \"POLG sequencing plus biochemical catalytic activity measurement in patient pedigrees (E873stop/A467T)\",\n      \"pmids\": [\"15122711\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contribution of each allele to the deficit not separated in this study\", \"Single lab\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved why the common A467T variant is pathogenic — it cripples turnover and abolishes p55 accessory-subunit interaction and processivity stimulation rather than acting through the exonuclease.\",\n      \"evidence\": \"Multiple orthogonal in vitro assays with purified recombinant A467T enzyme (processivity, immunoprecipitation, proteolysis protection)\",\n      \"pmids\": [\"16024923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of disrupted accessory-subunit binding not determined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Explained how a compound heterozygous genotype produces disease through mono-allelic expression, with the nonsense allele degraded by NMD.\",\n      \"evidence\": \"Western blot and RT-PCR of POLG transcripts in E873stop/A467T patient fibroblasts\",\n      \"pmids\": [\"16181814\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of NMD-driven mono-allelic expression across other POLG genotypes untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Distinguished the replication-stalling signature of POLG catalytic mutants from that of the Twinkle helicase, placing POLG within strand-asynchronous mtDNA replication.\",\n      \"evidence\": \"Expression of catalytic POLG mutants in human cells with analysis of replication intermediates\",\n      \"pmids\": [\"17452351\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define the molecular trigger of lagging-strand delay\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the genotype-function rule that depletion requires a catalytic-domain or nonsense lesion, whereas two linker mutations preserve copy number.\",\n      \"evidence\": \"mtDNA quantification across 24 patient fibroblast genotypes\",\n      \"pmids\": [\"18487244\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative; mechanistic basis of linker-only tolerance not biochemically tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Provided a mechanistically informative negative control by showing G517V retains activity, p55 interaction and DNA binding, refining variant pathogenicity criteria.\",\n      \"evidence\": \"Purified recombinant G517V biochemical assays (polymerase activity, accessory-subunit interaction, DNA binding)\",\n      \"pmids\": [\"21856450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavior in compound-heterozygous context not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected POLG proofreading loss to stem/progenitor cell dysfunction via redox imbalance, extending mtDNA fidelity to tissue homeostasis.\",\n      \"evidence\": \"PolgA mutator mouse with NSC/HPC assays and N-acetyl-L-cysteine rescue\",\n      \"pmids\": [\"22225879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise ROS source and downstream signaling not pinpointed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that heterozygous proofreading deficiency produces age- and tissue-specific mtDNA deletions and motor dysfunction without depletion or point-mutation load.\",\n      \"evidence\": \"Polg D257A knock-in mice with rotarod testing and tissue mtDNA deletion/point-mutation analysis\",\n      \"pmids\": [\"25540805\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism converting proofreading loss to deletions rather than point mutations unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified epigenetic methylation at POLG exon 2 as a regulator of mtDNA copy number tied to proliferation and differentiation state.\",\n      \"evidence\": \"MeDIP/hMeDIP, mtDNA qPCR, and 5-azacytidine demethylation across cancer and pluripotent cells\",\n      \"pmids\": [\"25719248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Enzymes setting/erasing the exon-2 mark not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed that POLG operates in two opposing modes — synthetic versus exonucleolytic degradation — governed by autophagy-dependent nucleotide and ROS homeostasis during starvation.\",\n      \"evidence\": \"Yeast autophagy mutants with mtDNA copy number, respiration, and nucleotide pool measurements\",\n      \"pmids\": [\"29519802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the same starvation switch operates in mammalian cells not shown here\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed that physiological dNTP concentration rate-limits POLG-mediated mtDNA repopulation, and that supplementation boosts copy number without sacrificing fidelity.\",\n      \"evidence\": \"Deoxyribonucleoside supplementation in quiescent patient fibroblasts with dNTP and deletion/mutation analysis\",\n      \"pmids\": [\"30848931\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not test fidelity effects in proofreading-mutant backgrounds\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established transcriptional control of POLG by ERα, linking nuclear hormone signaling to mtDNA maintenance in adipose tissue.\",\n      \"evidence\": \"ChIP for ERα at the Polg1 promoter plus adipose-selective Esr1 knockout mice\",\n      \"pmids\": [\"32759275\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ERα regulation of human POLG in non-adipose tissues untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Uncovered POLGARF, an overlapping CUG-initiated protein from the POLG leader with nucleolar localization, C1QBP interaction, and regulated secretion, expanding the locus's coding capacity.\",\n      \"evidence\": \"CUG-initiation reporter assays, live imaging, Co-IP with C1QBP, secretion assays, ribosome profiling, phylogenetics\",\n      \"pmids\": [\"32958672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological function of the secreted POLGARF fragment not defined\", \"Relationship between POLGARF and pol gamma activity unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified post-transcriptional control of POLG mRNA stability via an OIP5-AS1/HuR scaffold, coupling lncRNA regulation to mitochondrial integrity in lens cells.\",\n      \"evidence\": \"RIP-qPCR for OIP5-AS1/HuR/POLG mRNA plus POLG knockdown/overexpression with JC-1 and ROS readouts\",\n      \"pmids\": [\"33006594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality beyond lens epithelial cells unaddressed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed PARP1 relocalizes to mitochondria and directly binds and inhibits POLG-mediated mtDNA synthesis, defining a post-translational brake on replication.\",\n      \"evidence\": \"PARP1/POLG Co-IP, PARP1 knockdown, mitochondrial gene-expression and respiration readouts in VSMCs\",\n      \"pmids\": [\"37679327\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP without structural mapping of the interaction\", \"Direct vs indirect inhibition not fully separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended PARP1 regulation to PARylation- and ubiquitination-dependent POLG degradation driving ferroptosis and vascular calcification, linking POLG turnover to disease.\",\n      \"evidence\": \"PARP1 KO mice, POLG overexpression/knockdown in vivo, and IP for POLG PARylation and ubiquitination\",\n      \"pmids\": [\"40401372\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase mediating POLG ubiquitination not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected muscle POLG dysfunction to the mitochondrial integrated stress response and a specific folate-cycle metabolite depletion, a novel metabolic axis of mitochondrial disease.\",\n      \"evidence\": \"Inducible muscle-specific PolG mutant mice with metabolomics and mtISR pathway profiling\",\n      \"pmids\": [\"40057508\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal role of 5,10-methenyl-THF depletion in pathology not tested by rescue\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple regulatory layers — dNTP supply, autophagy, ERα transcription, exon-2 methylation, and PARP1-driven PTMs — are integrated to set POLG activity and mtDNA copy number in different tissues remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model coordinating transcriptional, post-transcriptional, and post-translational POLG control\", \"Physiological role of POLGARF relative to pol gamma undefined\", \"Structural basis of disease-mutation effects on the holoenzyme not solved within this corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 2, 3, 4, 9]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 4, 9, 12]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 13]}\n    ],\n    \"complexes\": [\"pol gamma holoenzyme (POLG\\u2013p55/POLG2)\"],\n    \"partners\": [\"POLG2\", \"PARP1\", \"C1QBP\", \"PKM2\", \"ESR1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}